Neuroscience
Meta-Analysis
100%
Antipsychotic
56%
Cannabinoid 1 Receptor
50%
Decision-Making
50%
Memory
50%
Benzodiazepine
50%
Agonist
37%
Tetrahydrocannabinol
37%
Spatial Memory
25%
Cannabis
18%
Negative Syndrome
14%
Automutilation
14%
Cannabinoid
12%
Cognitive Disorders
12%
Placebo
12%
Affective Psychosis
7%
Shared Decision Making
7%
Schizophrenia Spectrum Disorder
7%
Positive Syndrome
7%
Synaptic Transmission
6%
Cognitive Process
6%
Zopiclone
6%
Mental Disorder
6%
Synaptic Plasticity
6%
Cognitive Effect
6%
Memory Test
6%
Nervous System Disorder
6%
Hypnotic
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
56%
Cohort Study
56%
Tetrahydrocannabinol
50%
Benzodiazepine
50%
Cannabinoid 1 Receptor
50%
Clozapine
50%
Cannabis
30%
Haplorhini
20%
Cannabinoid
20%
Agonist-Antagonist
20%
Cognitive Defect
20%
Placebo
20%
Allosteric Modulator
20%
Side Effect
14%
Base
10%
Dronabinol
10%
Diseases
7%
Zopiclone
6%
Hypnotic
6%
Medicine and Dentistry
Meta-Analysis
50%
Clinical Significance
50%
Umbrella Review
50%
Negative Syndrome
14%
Automutilation
14%
Effect Size
7%
Mental Health Service
7%
Prognostic Factor
7%
Prospective Study
7%
Schizophrenia Spectrum Disorder
7%
Diseases
7%
Odds Ratio
7%
Affective Psychosis
7%
Positive Syndrome
7%